RAVINDER BHALLA: Open Payments
NPI 1841214566 · RIDGEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,945 in 15 payments from 4 companies in 2025. Trend: 2023 $38,510 · 2024 $15,340 · 2025 $6,945
Speaker / faculty: $6,230Food & beverage: $677Travel & lodging: $38
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $6,301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $370 |
| Otsuka America Pharmaceutical, Inc. | 2 | $245 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
Products named: AUSTEDO XR, CAPLYTA, REXULTI, Qelbree.
Industry payments across NJ — which companies pay providers there.
